Buspirone hydrochloride
- Product NDC
- 70934-859
- 11-digit product format
- 709340859
- Labeler code
- 70934
- Product ID
- 70934-859_c33e84ba-4c0e-f738-e053-2995a90aa20a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Buspirone hydrochloride
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Denton Pharma, Inc. DBA Northwind Pharmaceuticals
- Application
- ANDA202087
- Marketing category
- ANDA
- Marketing start
- 2021-05-26
- Marketing end
- 2023-10-31
- Substance
- BUSPIRONE HYDROCHLORIDE
- Active strength
- 15 mg/1
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| 207LT9J9OC | BUSPIRONE HYDROCHLORIDE | 33386-08-2 | BUSPIRONE HYDROCHLORIDE |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70934-859-30 | 70934085930 | 30 TABLET in 1 BOTTLE, PLASTIC (70934-859-30) | 30 tablet | 2021-05-26 | 2023-10-31 | No | No | Current |